Why invest: BloodSpeed unlocks a new layer of clinical data in one of the highest-volume diagnostic markets.

Unique selling point: First-in-class measurement of how efficiently blood delivers oxygen—not just how much it carries.

Opportunity: A large, underserved market with clear entry in blood banking and a scalable path to global adoption via OEM partnerships.

Where to start: Contact us my email